Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22315710 | 1.00 | HCAR2 (0.30) | HCAR2 | |
| Hydrochloric Acid SCHEMBL28701466 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL28701463 | 0.98 | — | — | |
| SCHEMBL22315716 | 0.82 | APLNR (0.31) | — | |
| SCHEMBL22316960 | 0.82 | APLNR (0.31) | — | |
| Hydrochloric Acid SCHEMBL25254223 | 0.70 | SLC22A6 (0.39) | — | |
| SCHEMBL15875530 | 0.70 | CYP4F2 (0.36) | HCAR2 | |
| SCHEMBL24083337 | 0.70 | HCAR2 (0.32) | HCAR2 | |
| SCHEMBL8773843 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL28678114 | 0.69 | CYP4F2 (0.36) | HCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113999236-B | Salt of nitrogen-containing heterocyclic compound and solid form, pharmaceutical composition and use of salt thereof | 武汉人福创新药物研发中心有限公司 | 2025-06-10 | — | — | CN | disclosed |
| CN-113999235-B | Solid forms of nitrogen-containing heterocyclic compounds, pharmaceutical compositions and uses thereof | 武汉人福创新药物研发中心有限公司 | 2025-06-10 | — | — | CN | disclosed |
| US-20230312582-A1 | Salts Of Nitrogen-Containing Heterocyclic Compound, And Solid Forms Of Salts, Pharmaceutical Composition And Use Thereof | Wuhan Humanwell Innovative Drug Research and Development Center Limited Company (CN) | 2023-10-05 | — | — | US | disclosed |
| US-20230312582-A1 | Salts Of Nitrogen-Containing Heterocyclic Compound, And Solid Forms Of Salts, Pharmaceutical Composition And Use Thereof | Wuhan Humanwell Innovative Drug Research and Development Center Limited Company (CN) | 2023-10-05 | — | — | US | disclosed |
| EP-4190783-A1 | SALTS OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, AND SOLID FORMS OF SALTS, PHARMACEUTICAL COMPOSITION AND USE THEREOF | Wuhan Humanwell Innovative Drug Research and Development Center Limited Company (CN) | 2023-06-07 | — | — | EP | disclosed |
| CN-111518101-B | Pyrrolopyrimidine derivatives and uses thereof | 武汉人福创新药物研发中心有限公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-113999236-A | Salt of nitrogen-containing heterocyclic compound and solid form, pharmaceutical composition and application of salt | 武汉人福创新药物研发中心有限公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-113999235-A | Solid forms of nitrogen-containing heterocyclic compounds, pharmaceutical compositions and uses thereof | 武汉人福创新药物研发中心有限公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-113943296-A | Pyrrolopyrimidine derivatives and uses thereof | 武汉人福创新药物研发中心有限公司 | 2022-01-18 | — | — | CN | disclosed |
| CN-111518101-A | Pyrrolopyrimidine derivatives and uses thereof | 湖北生物医药产业技术研究院有限公司 | 2020-08-11 | — | — | CN | disclosed |
| WO-2020156459-A1 | PYRROLOPYRIMIDINE DERIVATIVE AND USE THEREOF | 湖北生物医药产业技术研究院有限公司 | 2020-08-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230312582-A1 | Salts Of Nitrogen-Containing Heterocyclic Compound, And Solid Forms Of Salts, Pharmaceutical Composition And Use Thereof | ATXN10, ATXN2, ATXN2L | HCAR2 4017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.